Cargando…

Piperacillin induced bone marrow suppression: a case report

BACKGROUND: Piperacillin (and piperacillin/tazobactam) is a commonly prescribed antibiotic and is generally considered safe. We report a case of piperacillin induced bone marrow suppression. CASE PRESENTATION: A 19-year-old boy was being treated with piperacillin followed by piperacillin/tazobactam...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Ashish, Choudhuri, Gourdas, Aggarwal, Rakesh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165417/
https://www.ncbi.nlm.nih.gov/pubmed/12791166
http://dx.doi.org/10.1186/1472-6904-3-2
_version_ 1782120831500943360
author Kumar, Ashish
Choudhuri, Gourdas
Aggarwal, Rakesh
author_facet Kumar, Ashish
Choudhuri, Gourdas
Aggarwal, Rakesh
author_sort Kumar, Ashish
collection PubMed
description BACKGROUND: Piperacillin (and piperacillin/tazobactam) is a commonly prescribed antibiotic and is generally considered safe. We report a case of piperacillin induced bone marrow suppression. CASE PRESENTATION: A 19-year-old boy was being treated with piperacillin followed by piperacillin/tazobactam for infected pancreatic pseudocyst. After 21 days of treatment, he developed neutropenia and thrombocytopenia. These reversed promptly after stopping piperacillin/tazobactam. The time course of events suggested that piperacillin was the cause of bone marrow suppression in this patient. CONCLUSION: Bone marrow suppression is a serious adverse effect of piperacillin, which should be kept in mind while treating patients with this drug.
format Text
id pubmed-165417
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1654172003-07-16 Piperacillin induced bone marrow suppression: a case report Kumar, Ashish Choudhuri, Gourdas Aggarwal, Rakesh BMC Clin Pharmacol Case Report BACKGROUND: Piperacillin (and piperacillin/tazobactam) is a commonly prescribed antibiotic and is generally considered safe. We report a case of piperacillin induced bone marrow suppression. CASE PRESENTATION: A 19-year-old boy was being treated with piperacillin followed by piperacillin/tazobactam for infected pancreatic pseudocyst. After 21 days of treatment, he developed neutropenia and thrombocytopenia. These reversed promptly after stopping piperacillin/tazobactam. The time course of events suggested that piperacillin was the cause of bone marrow suppression in this patient. CONCLUSION: Bone marrow suppression is a serious adverse effect of piperacillin, which should be kept in mind while treating patients with this drug. BioMed Central 2003-06-05 /pmc/articles/PMC165417/ /pubmed/12791166 http://dx.doi.org/10.1186/1472-6904-3-2 Text en Copyright © 2003 Kumar et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Case Report
Kumar, Ashish
Choudhuri, Gourdas
Aggarwal, Rakesh
Piperacillin induced bone marrow suppression: a case report
title Piperacillin induced bone marrow suppression: a case report
title_full Piperacillin induced bone marrow suppression: a case report
title_fullStr Piperacillin induced bone marrow suppression: a case report
title_full_unstemmed Piperacillin induced bone marrow suppression: a case report
title_short Piperacillin induced bone marrow suppression: a case report
title_sort piperacillin induced bone marrow suppression: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165417/
https://www.ncbi.nlm.nih.gov/pubmed/12791166
http://dx.doi.org/10.1186/1472-6904-3-2
work_keys_str_mv AT kumarashish piperacillininducedbonemarrowsuppressionacasereport
AT choudhurigourdas piperacillininducedbonemarrowsuppressionacasereport
AT aggarwalrakesh piperacillininducedbonemarrowsuppressionacasereport